GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-08-23 14711db5m08(暂无昵称)

投稿4天，一直under review，是有可能送外审了吗？

176 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2022-03-19 145f93d9m65暂无昵称

病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错

104 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-09-08 14711db5m08(暂无昵称)

已经under review3周了，不知道还要多久

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2018-06-04 ms9526231670310936

最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！

139 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-07-05 cindichaw

先收费，两次均拒，令人不爽。后来有一篇发在gut上了

122 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-05-30 Leopard FD

审稿速度:1.0 | 投稿命中率:25.0
经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH

336 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-07-31 slientwo

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：胃肠疾病
经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！

1 0

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-03-31 壮壮一人暮

审稿速度:1.0 | 投稿命中率:5.0
经验分享：三天秒拒，果然大家风范~
虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。

269 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-11-26 12107b02m29(暂无昵称)

审稿速度:1.0 | 投稿命中率:5.0
经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！

206 0

[GetPortalCommentsPageByObjectIdResponse(id=1010699, encodeId=2efa101069941, content=投稿4天，一直under review，是有可能送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Mon Aug 23 19:58:57 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203936, encodeId=f4fb120393633, content=病例报告。投稿了一个罕见病的图片和视频，一审7天，三个编辑审稿，小修，返修后4天接受，总计历时2周。效率不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220127/c7fafee87de34006843418e6ae9b7904/8dad0e57bc12456696f9159afea0c1e4.jpg, createdBy=89155102548, createdName=145f93d9m65暂无昵称, createdTime=Sat Mar 19 00:58:51 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015557, encodeId=fd80101555e2c, content=已经under review3周了，不知道还要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cd75188935, createdName=14711db5m08(暂无昵称), createdTime=Wed Sep 08 08:41:43 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843719, encodeId=2ede843e19d5, content=最近接受一篇，不容易！除了要有明显的临床指导意义外，还需要大量的临床标本和数据支撑和详细的机制研究，多个动物模型验证，基因沉默需两种不同sirna，修回后补实验5个月接受，补实验的数据基本和原始投稿数据差不多了。分数涨了，要求也高了很多！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Mon Jun 04 23:17:21 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996574, encodeId=46ab9965e411, content=先收费，两次均拒，令人不爽。后来有一篇发在gut上了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Mon Jul 05 21:59:24 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571677, encodeId=e47a5e1677d3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：难！4月23号投稿，5月29号审完。拒稿。三个审稿人给了近一百条comments 。编辑让走快速通道，修完投CGH, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Thu May 30 00:00:00 CST 2019, time=2019-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004214, encodeId=8016100421447, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：胃肠疾病 经验分享：消化内科学界，无论基础还是临床，仍然是老大哥存在！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sat Jul 31 12:13:23 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587799, encodeId=3e8958e7993f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：三天秒拒，果然大家风范~ 虽然效率很高，但是提交杂志社就得交一笔75$的费用还是有点坑的。对自己的研究非常有信心的可以试试，毕竟高分。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c222020507, createdName=壮壮一人暮, createdTime=Tue Mar 31 09:20:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902554, encodeId=9bdb9025541c, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：非常好的杂志，编辑只说结果interesting，但是不够优秀。没有实质的意见可供参考！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51c02222748, createdName=12107b02m29(暂无昵称), createdTime=Thu Nov 26 17:20:56 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578793, encodeId=50fe5e87931c, content=等待中，太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

等待中，太长了

272 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务